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Abstract
Background: Adequate malaria diagnosis and treatment remain major difficulties in rural sub-
Saharan Africa. These issues deserve renewed attention in the light of first-line treatment with
expensive artemisinin-combination therapy (ACT) and changing patterns of transmission intensity.
This study describes diagnostic and treatment practices in Mto wa Mbu, an area that used to be
hyperendemic for malaria, but where no recent assessments of transmission intensity have been
conducted.
Methods: Retrospective and prospective data were collected from the two major village health
clinics. The diagnosis in prospectively collected data was confirmed by microscopy. The level of
transmission intensity was determined by entomological assessment and by estimating sero-
conversion rates using anti-malarial antibody responses.
Results: Malaria transmission intensity by serological assessment was equivalent to < 1 infectious
bites per person per year. Despite low transmission intensity, > 40% of outpatients attending the
clinics in 2006–2007 were diagnosed with malaria. Prospective data demonstrated a very high
overdiagnosis of malaria. Microscopy was unreliable with < 1% of slides regarded as malaria
parasite-positive by clinic microscopists being confirmed by trained research microscopists. In
addition, many 'slide negatives' received anti-malarial treatment. As a result, 99.6% (248/249) of the
individuals who were treated with ACT were in fact free of malaria parasites.
Conclusion: Transmission intensity has dropped considerably in the area of Mto wa Mbu. Despite
this, most fevers are still regarded and treated as malaria, thereby ignoring true causes of febrile
illness and over-prescribing ACT. The discrepancy between the perceived and actual level of
transmission intensity may be present in many areas in sub-Saharan Africa and calls for greater
efforts in defining levels of transmission on a local scale to help rational drug-prescribing behaviour.
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Background
Adequate diagnosis and prompt treatment of malaria
remain major difficulties in rural settings in sub-Saharan
Africa. In these areas, more than 70% of individuals with
symptoms suggestive of malaria treat fevers with anti-
malarial drugs without visiting the formal health sector
for diagnosis [1,2]. If people do visit a health facility, an
accurate diagnosis is not guaranteed. Microscopic exami-
nation of a blood smear is the gold standard method for
the diagnosis of malaria, but is often unavailable at sub-
district facilities [3]. In the absence of microscopy, malaria
diagnosis is based on clinical symptoms that are known to
lack specificity [4], or treatment is administered presump-
tively. Even if microscopy is available, there is substantial
overdiagnosis of malaria [5]. There is an urgent need to
review these diagnostic and treatment practices with the
wide-scale implementation of the relatively expensive
artemisinin-combination therapy (ACT) and in the light
of changing patterns of malaria transmission.
Presumptive treatment of malaria remains a useful tool
for malaria control in areas where malaria is common, the
risk of progression to severe malaria is significant, and
diagnostic facilities are lacking. In these areas, presump-
tive treatment is an effective strategy to increase the cover-
age of anti-malarials and may act to reduce transmission
of malaria [6]. However, the strategy may not be justifia-
ble for low endemic areas where the majority of febrile
episodes are not due to malaria [7] and over-diagnosis
and over-treatment of malaria are very common [4,8,9].
Knowledge of malaria transmission intensity can guide
clinicians in defining algorithms for dealing with febrile
patients. However, reliable estimates of malaria transmis-
sion intensity are frequently unavailable and transmission
intensity can change over time as a result of interventions
[10,11] or natural fluctuations [12]. Across the African
continent, there are reports of recent reductions in malaria
transmission intensity (reviewed in [6]).
Investigating how rural health systems function in the cur-
rent climate of changing transmission and efforts to con-
trol and eliminate malaria seems pertinent. Here,
diagnostic and treatment practices in rural health centres
in Mto wa Mbu are described, an area that was historically
hyperendemic for malaria [13], but where no recent
assessments of transmission intensity have been con-
ducted.
Methods
Study site
This study was conducted in Mto wa Mbu (latitude 3°
21'S; longitude 35° 51' E), which is translated from
Kiswahili as 'River of Mosquitoes'. The town is located in
the northern highlands of Tanzania at an altitude of 960
m – 1478 m above sea level and rain fall is largely
restricted to the short (Oct-Nov) and long rainy season
(March-July). According to a national census that was
conducted in 2002, the town has 16,068 inhabitants. Ret-
rospective and prospective data were collected from the
two major village health clinics: the clinic of the Evangel-
ical Lutheran Church (KKKT) and the Roman Catholic
Health Facility (RCHF).
Retrospective data
Both clinics routinely used microscopy for diagnosing
malaria and reported malaria to be their primary diagno-
sis in outpatients. Retrospective data consisted of infor-
mation from outpatient registers of the years 2006 and
2007. For each individual that presented at the clinic the
visit date, age and sex was recorded, as well as if they were
diagnosed with malaria (either by clinical assessment or
after detection of parasites by the clinic microscopist) and
whether anti-malarial treatment was given. Climatic data
were obtained from the nearby Lake Manyara National
Park.
Prospective data
Data was prospectively gathered from all individuals
attending the clinics as patients in the months May-
August 2007, at the end of the long rains when a high
number of malaria cases was expected [12,14]. All
patients were informed about the purpose of the study
and asked to give written consent before inclusion in the
study. Once enrolled, a brief questionnaire was adminis-
tered to collect information on: age, sex, bed net use, use
of antibiotics or anti-malarials in the previous two weeks
and symptoms. A single finger prick blood sample was
taken for serum collection on Whatman 3 MM filter paper
[Whatman, Maidstone, UK]. If individuals were referred
for malaria diagnosis, a finger prick blood sample was
taken for malaria parasite detection by Rapid Diagnostic
Test (RDT) and two blood slides. ParaHIT® RDTs [Span
Diagnostics Ltd, Surat, India]. RDTs were used according
to the manufacturer's instructions and were based on the
detection of Histidine Rich Protein 2. The first of the two
blood slides was stained at the clinic according to the
clinic's routine practice and scored by the microscopist
working at the clinic. This slide result and the RDT result
were made available to the clinician for diagnosis. The sec-
ond slide was later stained in a research lab and read by
two experienced research-microscopists. Parasite density
per 200 white blood cells was determined on the thick
smear and the slide was considered negative if no parasite
was observed in 100 microscopic fields. Results of the two
research microscopists were compared for validation and
all discordant were read by a third microscopist.
Individuals who were diagnosed with malaria by the clini-
cian received artemether-lumefantrine in line with the
Tanzanian national policy. This study received ethicalMalaria Journal 2008, 7:232 http://www.malariajournal.com/content/7/1/232
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clearance from the ethical board of the Kilimanjaro Chris-
tian Medical Centre (KCMC Ethical Clearance certificate
2007 #167).
Entomology
Mosquitoes were collected in 10 houses that were selected
to be representative of the different housing structures in
the village. Mosquitoes were caught with a standard Cen-
tre for Disease Control light traps (CDC, Atlanta, GA,
USA) every fortnight for three months (May – September
2007). Traps were hung at the end of an occupied bed
with an untreated bed net that was newly provided by the
investigators. Traps were set for 12 hours, from 7 pm to 7
am [15,16]. In the morning, traps were collected and mos-
quito species determined and counted. Male Anopheles
mosquitoes, Culicines and non-vector Anophelines were
discarded. Female Anopheles mosquitoes were stored on
silica gel for circumsporozoite protein (CSP) ELISA as
described by Wirtz et al [17]. The head and thorax were
removed for every mosquito, prepared for ELISA [17] and
stored in an uncoated 96-well microtitre plate until the
assays were performed. Samples were prepared individu-
ally and assayed with positive mosquitoes repeated. Insec-
tary reared unfed female Anophelines were used as
negative controls together with a commercially provided
CSP positive control [CDC, Atlanta, USA]. Samples were
read by eye and on an ELISA plate reader at 495 nm. The
EIR and confidence intervals were calculated as described
by Drakeley et al. [18]. A conversion factor was used to
adjust for the difference between light trap catches and
man biting catches, giving the formula: infectious bites
per person per month = 1.605 * (number of positive mos-
quitoes/number of traps) * 30 [18].
MSP-1 ELISA
Serum was eluted from filter papers as described by Cor-
ran  et al [19]. Immunoglobulin G antibodies against
blood stage antigens were detected by indirect ELISA, as
previously described [20] using recombinant MSP-119
(Wellcome genotype), which were produced as described
previously [21]. Briefly, flat bottom 96-well plates [Immu-
lon 4HBX, Thermo] were coated overnight with 50 μL of
0.5 mg/mL dilution of the specific antigen. After washing
with PBS-0.05% Tween [(PBS-T), 200 μL of blocking
buffer (1% skimmed milk in PBS-T) was added for 3
hours at room temperature. After washing, plasma sam-
ples were added in duplicate at a single dilution of 1/1000
and incubated at 4°C overnight. 100 μL of rabbit anti-
human IgG HRP Conjugate [Dako, Ely, UK] was added
and incubated for 1 hour at room temperature. Plates
were developed with o-phenyline-diamine [Sigma]-H2O2
and the reaction was stopped with 50 μL H2SO4. Plates
were read at 490 nm. To generate an OD cut-off value
above which samples were deemed antibody positive, the
distribution of OD values was fitted as the sum of two
Gaussian distributions (assuming a narrow distribution
of seronegatives and a broader distribution of seroposi-
tives) using maximum likelihood methods [19].
Data analysis
Statistical analyses of data were performed using SPSS ver-
sion 14.0 and Stata 9.2 (Stata Corp, College Station TX,
USA). Categorical variables were compared between
groups by the Pearson Chi-square test or Fisher's Exact
test, odds ratios (OR) with 95% confidence intervals
(95% CI) were calculated. MSP-119 ELISA data were used
to generate an age-seroprevalence plot. OD values were
expressed as percentage of the positive control (normal-
ised OD) The annual seroconversion rate, λ, and the
annual rate of reversion to seronegativity, ρ, were esti-
mated by fitting a simple model of the acquisition and
loss of antibodies to the age-specific prevalence of the
antibodies using maximum likelihood methods assuming
a binomial distribution [20]. The equivalent annual ento-
mological inoculation rate (EIR) was then estimated using
a calibration curve derived from previously determined
values [22].
Results
The perceived burden of malaria
In the period January 2006 – November 2007, the two
clinics registered a total of 22,553 outpatient visits. In this
period, 62.9% (1696/2696) of the outpatient visits of
children below five years of age were diagnosed with and
treated for malaria at the KKKT clinic, compared to 39.2%
(3284/8382) in individuals ≥ 5 years. In the RCHF, these
figures were 42.9% (1914/4466) and 42.1% (2948/
7009), respectively. There was no evident seasonal pattern
in the total number of malaria cases while clear peaks in
rainfall were recorded in the months of March-June and
October-December (Figure 1). Total rainfall was 650 mm
per annum.
The measured burden of malaria
Malaria case management and microscopically confirmed 
parasitaemia
The clinical management of malaria cases was observed in
the period June – August 2007 at both clinics. In the KKKT
clinic, 240 individuals attended the clinic with symptoms
that the clinician interpreted as suggestive of malaria (Fig-
ure 2); in the RC clinic this number was 88 (Figure 3).
Reported complaints, age and socio-demographic factors
were similar between the two clinics. The most commonly
reported complaint was fever (80.9%, 263/325) followed
by respiratory complaints (41.8%, 136/325). The median
age of suspected malaria cases was 26.5 years (IQR 10.0 –
38.0) and 51.5% (168/326) reported the use of anti-
malarials in the two weeks preceding their visit. Bed net
use was reported by 85.1% (417/490) of the individuals
without information on (recent) impregnation.Malaria Journal 2008, 7:232 http://www.malariajournal.com/content/7/1/232
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Slide and RDT results and the prescribed anti-malarial
treatment were summarized in Figures 2 and 3. A slide was
requested for almost all individuals with suspected
malaria (99.3% (326/328); the remaining two received
anti-malarials without laboratory testing. All individuals
who had parasites on their blood slide according to the
clinic microscopist received anti-malarial treatment, both
at the KKKT clinic and the RC clinic. Of those who were
considered parasite free by the clinic microscopist, 58.7%
(88/150) and 59.5% (22/37), nevertheless received anti-
malarials at the KKKT and RC clinic, respectively. At the
KKKT clinic 37.2% (89/239) of all requested slides were
scored positive by the microscopist but only one of these
'positive slides' was confirmed by the research micro-
scopists. The proportion of 'positive slides' was even
higher in the RC clinic where 57.5% (50/87) of all
requested slides was considered positive by the clinic
microscopist and none of these were positive when
stained and read by the research microscopists. One para-
site positive slide was missed by the microscopist in the
KKKT clinic (parasite density: 27,760 parasites/μL) and
was also RDT negative; this person received antibiotics,
but no anti-malarials. There was no statistically significant
association between slide positivity by the clinic micro-
scopists and the research microscopists (p = 0.84). Ten
individuals were positive by RDT, one of them was also
slide positive and two others reported the previous use of
anti-malarials.
When data of the two clinics were combined, the follow-
ing factors were associated to prescription of anti-malarial
drugs: the chance of receiving anti-malarials was increased
when the slide was scored positive by the clinic micro-
scopist (OR 1.70; 95% CI 1.51–1.92) and decreased in
case of reported cough (OR 0.50 95% CI 0.30 – 0.84).
Reported fever and reported previous use of anti-malarials
or antibiotics were not associated with the chance of
receiving anti-malarials at the clinic.
The entomological inoculation rate by mosquito sampling
A total of 70 CDC light traps were set in the period May-
September 2007. Of the mosquitoes caught, 15.6% (331/
2774) were of the Anopheles genus and 261 were female.
All female mosquitoes were processed and included in the
CSP ELISA, one was CS positive. This resulted in an esti-
mated entomological inoculation rate (EIR) of 0.69 (95%
CI 0.02 – 3.83) infectious bites per person per month for
the period surveyed.
Rainfall distribution and number of outpatient visits diagnosed with malaria Figure 1
Rainfall distribution and number of outpatient visits diagnosed with malaria. Bars indicate the number of clinically 
diagnosed malaria patients younger than five years of age (closed bars) or ≥ 5 years of age (open bars) in the KKKT and RCHF 
clinics combined in the period January 2006 – November 2007. The dashed line indicates the total monthly rainfall in mm/
month measured at the nearby Lake Manyara National Park.
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The entomological inoculation rate equivalent generated from 
seroprevalence data
A total of 464 serum samples were tested in the MSP119
ELISA. The overall seroprevalence of MSP119 antibodies
was 29.5% (137/464) and there was a clear increase in
seroprevalence with age (Figure 4). Based on the fitted
curve, the λ was estimated at 0.026 (95% CI 0.016 –
0.042), which corresponds to an estimated EIR of 0.70
(0.26 – 1.87) infectious bites per person per year.
Discussion
In the study area of Mto wa Mbu that is characterised by
low transmission intensity, an unrealistically high per-
ceived burden of malaria was observed. Forty percent of
outpatients were treated for malaria while this diagnosis
was not supported by blood slide or rapid test and was
improbable in the light of the actual level of transmission
intensity.
The level of malaria transmission intensity, as determined
by rapid entomological assessment and MSP-119 age-sero-
prevalence data [20], was low in the area of Mto wa Mbu.
The EIR estimate by entomological assessment was 0.7
infectious bites per person per month. This estimate was
obtained in the period after the long rains and probably
represents the peak exposure to infected mosquitoes. It is,
therefore, not surprising that it exceeds the EIR estimate
based on the MSP119 age-seroprevalence curve (0.7 infec-
tious bites per person per year) although the confidence
intervals for both methods overlap. In general, EIR by
entomological assessments is susceptible to seasonal fluc-
tuations [12], fluctuations that are smoothened out by the
immunologic assessment [20,22] that may, therefore, give
a more robust estimate. Either method will lead to the
conclusion that transmission intensity in Mto wa Mbu is
low. This is in contrast with cross-sectional surveys from
1981 [13], when parasitological surveys indicated that the
area was having a level of transmission intensity 'certainly
equal to and probably higher than that found in Muheza-
Ubembe' [13], an area that is still known to be hyperen-
demic for malaria [23]. Malaria transmission intensity
clearly decreased in last 25 years but the period in which
the reduction took place is unclear. (Recent) reductions in
transmission intensity can be detected in age seropreva-
lence curves when the force of infection (λ) is allowed to
change over time [22]. However, a variable λ did not
improve the fit of our curve (data not shown), and we
found no indications for a recent reduction in EIR. Similar
Management of individuals with suspected malaria at the KKKT clinic Figure 2
Management of individuals with suspected malaria at the KKKT clinic. Clinic slide = slide stained and read by clinic 
microscopist; research slide = slide stained and read by trained research microscopist; RDT = rapid diagnostic test
Suspected
malaria
240
Slide requested
239
Clinic slide +
37.2% (89/239)
RDT+ 2.2%
(2/89)
Clinic slide –
62.8% (150/239)
RDT+ 4.0%
(6/150)
Malaria
treatment
100.0%
(89/89)
No malaria
treatment
0.0% (0/0)
Malaria
treatment
58.7%
(88/150)
No malaria
treatment
41.3%
(62/150)
Research
slide +
1.1% (1/89)
RDT+
2.2% (2/89)
Research
slide +
0.0% (0/0)
RDT+
0.0% (0/0)
Research
slide +
0.0% (0/88)
RDT+
3.4% (3/88)
Research
slide +
1.7% (1/62)
RDT+
4.8% (3/62)Malaria Journal 2008, 7:232 http://www.malariajournal.com/content/7/1/232
Page 6 of 8
(page number not for citation purposes)
to its timing, the reasons for the reduction in EIR are
unclear. The use of chloroquinized salt can not explain
this since it was used in the 1960s and 70s and parasite
rates of 50–60% in children < 10 years of age were still
reported in 1981 [13]. Bed net coverage was high in the
study area, but the coverage with ITNs has only increased
in recent years [24] and also provides no plausible expla-
nation. Similar to other areas in Africa [6], the drop in
transmission intensity is not easily explainable. The high
use of anti-malarials for any fever treatment, as demon-
strated in this study, could have acted as mass prophylaxis
and reduced transmission over time [6], but this cannot
be proven.
Despite the low transmission intensity in the area of Mto
wa Mbu, more than forty percent of all outpatients who
attended two major clinics over a period of almost two
years were diagnosed with malaria. There was no seasonal
pattern in malaria diagnoses, as is commonly observed
[12,14]. Prospective data from more than 400 suspected
malaria cases demonstrate that there was a massive over-
diagnosis of malaria in the two clinics. Despite the availa-
bility of microscopes, experienced microscopists and
clinicians, who frequently requested slides, the targeting
of anti-malarials appeared to be unimproved [5,25]. One
major explanation for this was that slide readings were
unreliable in the clinics included in this study: less than
1% of slides that were regarded as malaria parasite-posi-
tive by clinic microscopists were confirmed by trained
research microscopists. In addition, clinicians appeared to
use blood slide results more as a tool to confirm their clin-
ical suspicion rather than to rule out malaria [25]. All
individuals with 'positive slides' received anti-malarial
treatment although a 'negative slide' did by no means rule
out treatment [9]. This could be a result of the deeply
entrenched belief in slide negative malaria. It is true that
clinical malaria can result from low density parasitaemia
in low endemic areas and malaria can therefore not
always be ruled out in slide-negative cases [4]. However,
these are exceptional cases and restricting anti-malarials to
true microscopy-positives is a safe approach, even in areas
of low endemicity [8]. The prescription of anti-malarials
in Mto wa Mbu was clearly out of proportion. An astound-
ing 99.6% (248/249) of the individuals who were treated
with artemether-lumefantrine (AL) was free of malaria
parasites.
Management of individuals with suspected malaria the RCHF clinic Figure 3
Management of individuals with suspected malaria the RCHF clinic. Clinic slide = slide stained and read by clinic 
microscopist; research slide = slide stained and read by trained research microscopist; RDT = rapid diagnostic test
Suspected
malaria
88
Slide requested
87
Clinic slide +
57.5% (50/87)
RDT+ 4.0%
(2/50)
Clinic slide –
42.5% (37/87)
RDT+ 0.0%
(0/37)
Malaria
treatment
100.0%
(50/50)
No malaria
treatment
0.0% (0/0)
Malaria
treatment
59.5%
(22/37)
No malaria
treatment
40.5%
(15/37)
Research
slide +
0.0% (0/50)
RDT+
4.0% (2/50)
Research
slide +
0.0% (0/0)
RDT+
0.0% (0/0)
Research
slide +:
0.0% (0/22)
RDT +
0.0% (0/22)
Research
slide +
0.0% (0/15)
RDT +
0.0% (0/15)Malaria Journal 2008, 7:232 http://www.malariajournal.com/content/7/1/232
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Although a recently published hypothesis suggests that
overdiagnosis and overtreatment of malaria can have a
beneficial prophylactic effect in malaria control [6], the
current findings are worrying for several reasons. Firstly,
our area is of low endemicity and a beneficial prophylactic
effect is unlikely [6]. Secondly, diagnosis of malaria and
according treatment may simply be a 'convenient' clinical
strategy avoiding the more complicated search for other
causes of the presenting illness [25]. Treatment of all
febrile episodes as malaria is likely to result in underdiag-
nosis of other fever-causing disorders such as childhood
pneumonia [2]. Thirdly, over-treatment occurred with the
expensive AL. AL and other ACTs are typically 10-times
more expensive then previously used drugs as sulphadox-
ine-pyrimethamine [26,27] making reliable diagnosis cru-
cial for cost-effective use [28]. The artemisinin component
in ACT also do not have the prophylactic effect that was
suggested to be beneficial in 'opportunistic presumptive
treatment' [6]. Artemisinin is eliminated from the circula-
tion in a matter of hours [29] leaving the partner drug, in
this case lumefantrine, unprotected. That leads us to the
fourth reason for unease. There is concern for a reduced
susceptibility of P. falciparum parasites for ACT [29] and
the spread of parasites with reduced susceptibility to ACT
may be enhanced by irrational drug use [30]. Reports on
allelic selection after artemether-lumefantrine [31] pro-
vide additional warnings against over-use of ACT.
For a way forward, it is important to understand why there
is so much overdiagnosis and overtreatment in the study
area. A recent study elsewhere in Tanzania has demon-
strated that patient pressure, traditionally mentioned as a
major contributor [32], may not be important in over-
treatment [33]. Patients often prefer to be slide-tested and
treated in line with results [33]. In the clinics in Mto wa
Mbu, slide reading was clearly inadequate. Microscopists
will need additional training and in addition, more objec-
tive diagnostic tools such as RDTs can play a role in the
improvement of diagnosis. Clinicians in this study felt
uncomfortable to rule out malaria based on a negative
RDT (and one patient in our study was in fact a false RDT
negative). Time will be needed to make them consider
RDTs as useful diagnostic tools [34]. Perhaps delivering a
message to health workers and the public explaining that
malaria control has been successful in some areas and
malaria has truly been reduced may improve the situa-
tion. If both health staff and public understand that this
fever may not be due to malaria quality of care may
improve and "routine overdiagnosis" may be a story of
the past.
Conclusion
The observed discrepancy between the perceived and
actual level of transmission intensity may be present in
many areas in sub-Saharan Africa and calls for greater
efforts in defining levels of transmission on a local scale.
National policies may have to give way to more sensible
local policies that use proven multiple interventions in
areas of high-moderate transmission and focus on accu-
rate diagnosis and treatment in low transmission settings.
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